La cadena de opciones muestra datos clave de las opciones de acciones de ScanSource a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para ScanSource..

ScanSource (NASDAQ:SCSC) Bolsa, Cadena de Opciones

ScanSource

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

AAPL

SCSC

XWEL

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: SCSC, XWEL, PVH, AAPL y JWN.

5 acciones en el foco este martes: SCSC, XWEL, PVH, AAPL y JWN

ScanSource Inc

WIIM

ADEA

AEIS

AEVA

AGYS

AIOT

ALAB

ALAR

ALGM

AMPG

AMPL

ARLO

ASGN

ASTI

ATOM

BASE

BBAI

BELFA

BELFB

BIGC

BLBX

BLZE

BTCT

BZAI

CAMT

CCCS

CCRD

CEVA

CGNX

CLMB

CMPO

COHU

CRDO

CRNC

CRSR

CSIQ

CSPI

CTSH

CWAN

CXDO

DAKT

DAVA

DCBO

DGII

DIOD

DJCO

DMRC

DOCN

DOMO

EBON

EPAM

ETWO

EVCM

EVLV

EXFY

FARO

FCUV

FLEX

FSLR

GDYN

GRRR

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IDCC

INFA

INFY

INGM

INSG

IONQ

IPGP

ITRI

JAMF

Shares of broader tech companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

ScanSource shares are trading lower after the company reported worse-than-expected Q2 financial results.

Annual Financial Outlook for Fiscal Year 2025
ScanSource reaffirms previously provided guidance set forth below for the full fiscal year ended June 30, 2025.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">FY25 Annual Outlook</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net sales</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$3.1 billion to $3.5 billion</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA (non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$140 million to $160 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Free cash flow (non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">At least $70 million</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

Guidance

ScanSource Reaffirms Its FY25 Guidance: Sees Net Sales Of $3.1B–$3.5B Vs. $3.439B Est.; Adjusted EBITDA Of $140M–$160M, And Free Cash Flow Of At Least $70M

ScanSource (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>) announced its Q2 earnings on Thursday, January 30, 2025 at 08:30 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
ScanSource missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.85 versus an estimate of $0.91.
Revenue was down $137.29 million from the same period last year.
<h3>Historical Earnings Summary</h3>
The company beat on EPS by $0.07 in the previous quarter, leading to a 2.0% increase share price change the next day.
Here's a look at ScanSource's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.93</td>
<td>0.84</td>
<td>0.97</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.84</td>
<td>0.80</td>
<td>0.69</td>
<td>0.85</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>783.17M</td>
<td>843.14M</td>
<td>822.71M</td>
<td>945.60M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>775.58M</td>
<td>746.11M</td>
<td>752.60M</td>
<td>884.79M</td>
</tr>
</tbody>
</table>

To track all earnings releases for ScanSource <a href="https://www.benzinga.com/quote/SCSC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ScanSource: Q2 Earnings Insights

ScanSource (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.91 by 6.59 percent. This is unchanged from the same period last year. The company reported quarterly sales of $747.497 million which missed the analyst consensus estimate of $847.600 million by 11.81 percent. This is a 15.52 percent decrease over sales of $884.792 million the same period last year.

Earnings Misses

ScanSource Q2 2025 Adj. EPS $0.85 Misses $0.91 Estimate, Sales $747.497M Miss $847.600M Estimate

ABCB

APPF

Adtalem Global Education Inc. Common Stock

ATGE

BAFN

BBVA

BHLB

BOOT

CACC

CHKP

CIVB

CMCSA

CNOB

COUR

CSWI

CVCO

DECK

FBIZ

FCFS

FFWM

FINW

FISI

FLWS

FRME

GSIT

INTC

KLAC

KRNY

LPLA

MBLY

MBUU

NTCT

ONEW

PFSI

REAL

SHEL

SILC

SIRI

SKYW

STBA

STEL

Earnings Scheduled For January 30, 2025

ScanSource Reiterated FY25 Revenues Of $3.1B-$3.5B Vs. $3.31B Estimate And Free Cash Flow (Non-GAAP) Of At least $70M

Earnings Beats

ScanSource Q1 2025 Adj. EPS $0.84 Beats $0.77 Estimate, Sales $775.580M Miss $783.167M Estimate

ANET

AVGO

AWRE

BOXL

CMTL

CNXN

COHR

CSCO

DELL

EXTR

FFIV

FORM

FRSH

KEYS

KODK

LASR

LITE

NOVT

NTAP

NVEC

Next Technology Holding Inc. - Ordinary Shares

NXTT

OSIS

PLUS

PLXS

PMTS

PSTG

QMCO

QTWO

SANM

SITM

TTMI

VIAV

WOLF

ZBRA

Shares of companies within the broader technology sector are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

ScanSource (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>) is set to give its latest quarterly earnings report on Thursday, 2024-11-07. Here's what investors need to know before the announcement.
Analysts estimate that ScanSource will report an earnings per share (EPS) of $0.77. 
Anticipation surrounds ScanSource's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS missed by $0.13, leading to a 8.35% increase in the share price on the subsequent day.
Here's a look at ScanSource's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.93</td>
<td>0.84</td>
<td>0.97</td>
<td>0.91</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.80</td>
<td>0.69</td>
<td>0.85</td>
<td>0.74</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>4.0%</td>
<td>2.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730912613_0.png" alt="eps graph" />
<h3>Market Performance of ScanSource's Stock</h3>
Shares of ScanSource were trading at $44.61 as of November 05. Over the last 52-week period, shares are up 77.82%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SCSC/earnings">To track all earnings releases for ScanSource visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of ScanSource's Earnings

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, with the index in the &#8220;Neutral&#8221; zone on Tuesday.
U.S. stocks settled slightly higher on Tuesday, ahead of earnings reports from NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Traders are expecting the Federal Reserve to cut rates by at least 25 basis points at the Sept. 17-18 policy meeting.
ScanSource, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>) reported worse-than-expected fourth-quarter financial results. American Woodmark Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMWD#NASDAQ">AMWD</a>) shares fell around 11% after the company reported worse-than-expected first-quarter financial results and expects FY25 sales to decline in low single digits.
On the economic data front, the S&amp;P CoreLogic Case-Shiller home price index climbed by 6.5% year-over-year in June compared to a revised 6.9% rise in the prior month. The FHFA house price index fell 0.1% in June, compared to market expectations for a 0.2% gain.
Most sectors on the S&amp;P 500 closed on a positive note, with financials, information technology and real estate stocks recording the biggest gains on Tuesday. However, energy and utilities stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 10 points to 41,250.50 on Tuesday. The S&amp;P 500 rose 0.16% to 5,625.80, while the Nasdaq Composite gained 0.16% at 17,754.82 during Tuesday's session.
Investors are awaiting earnings results from NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) and The J. M. Smucker Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) today.
At a current reading of 52.9, the index moved to the &#8220;Neutral&#8221; zone on Tuesday, versus a prior reading of 43.6.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40576188/microsoft-synaptics-and-2-other-stocks-executives-are-selling">Microsoft, Synaptics And 2 Other Stocks Executives Are Selling</a></li>
</ul>

AMWD

NVDA

S&P Edges Higher Ahead Of Nvidia Earnings: Investors Sentiment Improves

ScanSource, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>)&nbsp;reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40574155/scansource-reports-fourth-quarter-and-full-year-results" rel="noreferrer noopener">fourth-quarter revenues</a> of $746.1 million, down 21.2% year-on-year. Revenues&nbsp;trailed the street view of $843.1 million.
Adjusted EPS of $0.80 missed the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $0.93</a>. The stock plunged after the disappointing print.
Specialty Technology Solutions&#8217; net sales for the fourth quarter decreased 13.7% year-over-year to $484.7 million due to softer demand.
Modern Communications &amp; Cloud&#8217;s net sales for the fourth quarter decreased 32.2% year-over-year to $261.4 million due to lower sales volumes in communications hardware and Cisco products. Intelisys net sales for the fourth quarter increased 6.2% year-over-year.
Gross profit fell 10.4% to $97.3 million. Gross margin improved to 13.04% from 11.47% in the year-ago period, reflecting Intelisys&#8217;s higher contribution to the overall revenue mix.
For the fourth quarter, operating income was $21.9 million compared to $27.3 million in the prior year quarter. Adjusted EBITDA for the fourth quarter decreased 15.0% Y/Y to $34.2 million, or 4.58% of net sales.
The company exited the quarter with cash and equivalents worth $185.5 million. It generated $53.5 million in free cash flow.
&#8220;Our results for the year reflect a soft demand environment; however, we delivered strong margins and robust cash flow,&#8221; said Mike Baur, Chair and CEO of ScanSource. &#8220;We are executing well on our capital allocation plan to invest in strategic acquisitions and share repurchases.&#8221;
Outlook:&nbsp;ScanSource expects fiscal 2025&nbsp;net sales growth of $3.10 billion-$3.50 billion versus <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$3.36 billion estimate</a>. The company projects an adjusted EBITDA of $140 million-$160 million. It expects an adjusted free cash flow of at least $70 million.
Analyst Rating: On August 15, Raymond James analyst Adam Tindle <a target="_blank" href="https://www.benzinga.com/quote/SCSC/analyst-ratings" rel="noreferrer noopener">downgraded ScanSource&#8217;s rating</a> from Outperform to Market Perform.&nbsp;
ScanSource stock gained 47% in the last 12 months.
Price Action:&nbsp;SCSC stock traded lower by 3.29% to $47.30 at the last check Tuesday.

Equities

Movers

ScanSource Q4: Earnings Fall Short, Specialty Tech Sales Decline, Intelisys Contribution Lifts Margins

U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 50 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.16% to 41,240.52 while the NASDAQ fell 0.42% to 17,651.68. The S&amp;P 500 also fell, dropping, 0.22% to 5,604.73.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40575289/jim-cramer-believes-in-dell-ceo-doesnt-like-b-g-foods">Jim Cramer Believes In Dell CEO, Doesn&#8217;t Like B&amp;G Foods</a>
Leading and Lagging Sectors Health care shares climbed by 0.2% on Tuesday.
In trading on Tuesday, information technology shares fell by 0.6%.
Top Headline
ScanSource, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCSC#NASDAQ">SCSC</a>) reported worse-than-expected fourth-quarter financial results.
ScanSource reported quarterly earnings of 80 cents per share which missed the analyst consensus estimate of 93 cents per share. The company reported quarterly sales of $746.113 million which missed the analyst consensus estimate of $843.143 million.
ScanSource said it sees FY25 revenues of $3.1 billion to $3.5 billion, versus estimates of $3.47 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares shot up 66% to $0.7176 after the company received a $14 million multi-year grant from the NIH for the continued development of its PF614-MPAR, an abuse-deterrent opioid with overdose protection.</li>
<li>Shares of Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) got a boost, surging 64% to $12.25 after the company and Indivior selected clinical candidates from their GABAB positive allosteric modulator research collaboration. The company is eligible for up to $330 million on achievement of milestones and royalties.</li>
<li>VOXX International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOXX#NASDAQ">VOXX</a>) shares were also up, gaining 50% to $4.25 after announcing strategic alternatives process to maximize valuation.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Altisource Asset Management Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAMC#NASDAQ">AAMC</a>) shares dropped 47% to $1.25 after the company announced intention to voluntarily delist and deregister its common stock from the NYSE American LLC.</li>
<li>Shares of COSCIENS Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCI#NASDAQ">CSCI</a>) were down 35% to $3.80 after the company announced results from Phase 3 DETECT-trial of AEZS-130-P02.</li>
<li>Lixte Biotechnology Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) was down, falling 15% to $1.75.</li>
</ul>
Commodities In commodity news, oil traded down 1% to $76.67 while gold traded down 0.4% at $2,545.10.
Silver traded down 0.3% to $29.92 on Tuesday, while copper rose 0.3% to $4.2915.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.1%, Germany's DAX rose 0.4% and France's CAC 40 fell 0.2%. Spain's IBEX 35 Index rose 0.2%, while London's FTSE 100 rose 0.2%.
German economy contracted by 0.1% quarter-over-quarter in the second quarter, following a 0.2% growth in the first quarter. The GfK Consumer Climate Indicator for Germany fell to a reading of -22.0 heading into September compared to a revised -18.6 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.47%, Hong Kong's Hang Seng Index gaining 0.43%, China's Shanghai Composite Index falling 0.24% and India's BSE Sensex rising 0.02%.
Hong Kong&#8217;s trade deficit narrowed to $21.8 billion in July versus a $30 billion gap in the year-ago month, as exports increased more than imports.
Economics
<ul>
<li>The S&amp;P CoreLogic Case-Shiller home price index climbed by 6.5% year-over-year in June compared to a revised 6.9% rise in the prior month.</li>
<li>The FHFA house price index fell 0.1% in June, compared to market expectations for a 0.2% gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40574236/netflix-to-rally-around-9-here-are-10-top-analyst-forecasts-for-tuesday">Netflix To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday</a></li>
</ul>

Eurozone

Commodities

Intraday Update

AAMC

ADXN

CSCI

ENSC

LIXT

VOXX

US Stocks Mixed; ScanSource Reports Weak Q4 Results

ScanSource shares are trading lower after the company reported worse-than-expected Q4 financial results.

ScanSource Expects FY25 Revenues Of $3.1B-$3.5B Vs. $3.47B Estimate; Sees Free Cash Flow (Non-GAAP) Of At least $70M

Comments

ScanSource

ScanSource (SCSC) Opciones

ScanSource (NASDAQ:SCSC) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL